Rare diseases
Investigational molecules
Locations
Back to France1 099 clinical trials in Montpellier, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
FranceStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
FranceStudy on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
FranceStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
FranceStudy on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments
FranceStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
FranceStudy of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
FranceStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
FranceStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
FranceStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
FranceStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, bladder cancer, and mantle cell lymphoma. Studies evaluate combination therapies and novel treatment approaches for improved patient outcomes.
Research includes evaluation of immunotherapy combinations and targeted molecular approaches.
Studies examining innovative treatments for Crohn's disease, multiple sclerosis, and systemic sclerosis. Research focuses on novel therapeutic approaches and treatment optimization.
Trials aim to improve disease management and patient quality of life.
Investigating treatments for achondroplasia, pyruvate dehydrogenase deficiency, and thyroid eye disease. Focus on developing targeted therapies for these uncommon conditions.
Research aims to address unmet medical needs in rare disease populations.
Clinical trials evaluating vaccines for cytomegalovirus, yellow fever, and HPV prevention. Studies focus on immunization effectiveness and safety profiles.
Research emphasizes disease prevention and public health improvement.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
